Visualitza per autor "de la Cruz-Merino, Luis"
Ara mostrant els elements 1-3 d 3
-
Pembrolizumab in combination with gemcitabine for patients with HER2-negative advanced breast cancer: GEICAM/2015–04 (PANGEA-Breast) study
de la Cruz-Merino, Luis; Gion, María; Alonso Romero, José Luis; Quiroga, Vanesa; Moreno, Fernando; Cortés Castan, Javier; Cruz, Josefina (BMC, 2022-12-03) -
Pembrolizumab Plus Gemcitabine in the Subset of Triple-Negative Advanced Breast Cancer Patients in the GEICAM/2015-04 (PANGEA-Breast) Study
de la Cruz-Merino, Luis; Gion, María; Cruz Jurado, Josefina; Quiroga, Vanesa; Andrés, Raquel; Moreno, Fernando; Cortés Castan, Javier (MDPI, 2021-10-29) -
SEOM clinical guidelines in advanced and recurrent breast cancer (2018)
Chacón López‑Muñiz, J. I.; de la Cruz-Merino, Luis; Gavilá Gregori, Joaquín; Martínez Dueñas, E.; Antunes de Melo Oliveira, Ana Mafalda; Seguí Palmer, M. A.; Bellet Ezquerra, Meritxell (Springer, 2019-01)